- Motley Fool•7 minutes ago
Looking for biotech stocks you don't need to worry about holding? We think these three are great for a long-term portfolio.
- Market Realist•42 minutes ago
Celgene (CELG) is focusing on myeloid disorders such as myelodysplastic syndromes (or MDS) and acute myeloid leukemia (or AML) as potential future growth opportunities.
- Market Realist•16 hours ago
Celgene (CELG) has a comprehensive strategy to target patient segments with unmet demands. It's expected to continue to dominate the multiple myeloma space in 2017.
CELG : Summary for Celgene Corporation - Yahoo Finance
Celgene Corporation (CELG)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||112.05 x 100|
|Ask||113.11 x 100|
|Day's Range||111.63 - 113.36|
|52 Week Range||93.05 - 127.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||42.65|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|